Caris Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Caris Life Sciences
CAI Stock  USD 20.62  0.03  0.15%   
Caris Life's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Caris Life's valuation are provided below:
Gross Profit
211.4 M
Profit Margin
(0.60)
Market Capitalization
7.9 B
Enterprise Value Revenue
18.4
Revenue
452.5 M
We have found one hundred twenty available fundamental signals for Caris Life Sciences, which can be analyzed and compared to other ratios and to its rivals. Traders should compare all of Caris Life Sciences prevailing fundamentals against the fundamentals between 2010 and 2026 to make sure the company is sustainable this year.

Caris Life Total Revenue

497.8 Million

Check Caris Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Caris Life's main balance sheet or income statement drivers, such as Depreciation And Amortization of 61.8 M, Interest Expense of 33.1 M or Total Revenue of 497.8 M, as well as many indicators such as Price To Sales Ratio of 16.34, Dividend Yield of 0.0333 or Days Sales Outstanding of 175. Caris financial statements analysis is a perfect complement when working with Caris Life Valuation or Volatility modules.
  
Build AI portfolio with Caris Stock
Check out the analysis of Caris Life Correlation against competitors.

Caris Life Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets375.5 M395.3 M1.4 B
Slightly volatile
Short and Long Term Debt Total871.9 M487.9 M1 B
Pretty Stable
Net Debt393.6 M414.4 M934.1 M
Pretty Stable
Cash38.8 M73.5 M50.7 M
Slightly volatile
Other Assets150 M163.8 M179.7 M
Slightly volatile
Cash And Short Term Investments73.1 M76.1 M108.5 M
Slightly volatile
Common Stock Shares Outstanding307.5 M292.9 M108.2 M
Slightly volatile
Liabilities And Stockholders Equity375.5 M395.3 M1.4 B
Slightly volatile
Non Current Liabilities Total3.2 B3.1 B1.7 B
Slightly volatile
Total Liabilities3.4 B3.3 B1.9 B
Slightly volatile
Total Current Assets165 M248.1 M218 M
Slightly volatile
Other Current Liabilities65.2 M73.6 M60.5 M
Slightly volatile
Total Current Liabilities178.4 M190.2 M189.1 M
Pretty Stable
Property Plant And Equipment Net112.3 M118.2 M1 B
Slightly volatile
Accounts Payable33.6 M32 M15.1 M
Slightly volatile
Non Current Assets Total139.8 M147.2 M1.2 B
Slightly volatile
Non Currrent Assets Other6.4 M6.8 M59.7 M
Very volatile
Net Receivables79.8 M101.5 M83.4 M
Pretty Stable
Short Term Debt96.1 M76.1 M108.6 M
Very volatile
Common Stock32.5 K34.2 K174 K
Slightly volatile
Current Deferred Revenue6.7 M8.6 M6.4 M
Very volatile
Good Will18 M17.4 M15.3 M
Pretty Stable
Intangible Assets3.5 M3.7 M4 M
Pretty Stable
Short Term Investments2.4 M2.5 M61 M
Slightly volatile
Long Term Debt240.1 M367.1 M193.9 M
Slightly volatile
Capital Lease Obligations38.6 M40.6 M47.4 M
Slightly volatile
Inventory36.1 M35.6 M45.3 M
Slightly volatile
Property Plant And Equipment Gross343.3 M381.1 M290.5 M
Slightly volatile
Short and Long Term Debt41.4 M69 M50.4 M
Pretty Stable
Capital Stock57.1 K34.2 K115.4 K
Slightly volatile
Net Working Capital43 M45.3 M306.8 M
Slightly volatile

Caris Life Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization61.8 M56.2 M73.1 M
Very volatile
Interest Expense33.1 M57.5 M41.2 M
Slightly volatile
Total Revenue497.8 M474.1 M295.9 M
Slightly volatile
Gross Profit124.7 M205.6 M139.9 M
Pretty Stable
Other Operating Expenses808.3 M769.8 M342.9 M
Slightly volatile
Total Operating Expenses526.4 M501.3 M192.3 M
Slightly volatile
Cost Of Revenue281.9 M268.5 M150.7 M
Slightly volatile
Selling General Administrative209.6 M199.6 M81.6 M
Slightly volatile
Interest Income7.1 M8.2 M2.7 M
Slightly volatile
Selling And Marketing Expenses156.3 M170.5 M142 M
Slightly volatile
Research Development121.8 M131 M105.9 M
Slightly volatile
Reconciled Depreciation53.6 M56.2 M49.1 M
Slightly volatile

Caris Life Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation61.8 M56.2 M73.1 M
Very volatile
Capital Expenditures9.2 M9.7 M254.4 M
Slightly volatile
Other Cashflows From Investing Activities224 M213.3 M116.8 M
Slightly volatile
Begin Period Cash Flow78.9 M69 M123.8 M
Slightly volatile
Dividends Paid21.4 M20.4 M9.8 M
Slightly volatile
Stock Based Compensation22.5 M21.4 M8.4 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio16.3415.579.5795
Slightly volatile
Dividend Yield0.03330.03170.0181
Slightly volatile
Days Sales Outstanding17589.85116
Slightly volatile
Stock Based Compensation To Revenue0.04270.04070.0258
Slightly volatile
Capex To Depreciation0.190.23.6009
Slightly volatile
EV To Sales9.716.3512.526
Slightly volatile
Inventory Turnover3.775.314.0479
Slightly volatile
Days Of Inventory On Hand88.1471.1491.3001
Slightly volatile
Payables Turnover8.467.5612.1807
Pretty Stable
Sales General And Administrative To Revenue0.40.380.2394
Slightly volatile
Research And Ddevelopement To Revenue0.390.320.3801
Slightly volatile
Capex To Revenue0.02240.02361.1016
Slightly volatile
Cash Per Share0.220.232.3317
Pretty Stable
Payout Ratio0.60.570.2953
Slightly volatile
Days Payables Outstanding47.4649.96111
Slightly volatile
Income Quality0.740.783.8217
Pretty Stable
Intangibles To Total Assets0.03670.06470.0312
Very volatile
Current Ratio0.941.171.331
Slightly volatile
Receivables Turnover2.384.23.5942
Slightly volatile
Capex Per Share0.02830.029812.5584
Slightly volatile
Revenue Per Share1.381.468.9779
Slightly volatile
Interest Debt Per Share1.591.6846.1614
Slightly volatile
Debt To Assets1.171.110.7244
Slightly volatile
Graham Number20.5333.1932.8742
Pretty Stable
Operating Cycle189161141
Slightly volatile
Days Of Payables Outstanding47.4649.96111
Slightly volatile
Dividend Payout Ratio0.60.570.2953
Slightly volatile
Quick Ratio0.90.961.2316
Slightly volatile
Net Income Per E B T0.680.850.862
Very volatile
Cash Ratio0.220.350.3076
Slightly volatile
Days Of Inventory Outstanding88.1471.1491.3001
Slightly volatile
Days Of Sales Outstanding17589.85116
Slightly volatile
Fixed Asset Turnover8.784.619.7528
Slightly volatile
Debt Ratio1.171.110.7244
Slightly volatile
Price Sales Ratio16.3415.579.5795
Slightly volatile
Asset Turnover1.131.080.379
Slightly volatile
Gross Profit Margin0.720.50.5636
Slightly volatile

Caris Fundamental Market Drivers

About Caris Life Financial Statements

Investors use fundamental indicators, such as Caris Life's revenue or net income, to determine how well the company is positioned to perform in the future. Although Caris Life's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Current Deferred Revenue8.6 M6.7 M
Total Revenue474.1 M497.8 M
Cost Of Revenue268.5 M281.9 M
Stock Based Compensation To Revenue 0.04  0.04 
Sales General And Administrative To Revenue 0.38  0.40 
Research And Ddevelopement To Revenue 0.32  0.39 
Capex To Revenue 0.02  0.02 
Revenue Per Share 1.46  1.38 
Ebit Per Revenue(0.72)(0.68)

Currently Active Assets on Macroaxis

FSLYFastly Class A
MOBMobilicom Limited American
CMGChipotle Mexican Grill
CSANCosan SA ADR
RKTRocket Companies
When determining whether Caris Life Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Caris Life's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Caris Life Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Caris Life Sciences Stock:
How To Invest In Caris
Details
Is Caris Stock a good investment?
Details
What is Caris Life's Net Worth?
Details
Largest Trading Companies & Distributors Companies
View
Largest Capital Goods Companies
View
Check out the analysis of Caris Life Correlation against competitors.
You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is there potential for Trading Companies & Distributors market expansion? Will Caris introduce new products? Factors like these will boost the valuation of Caris Life. Projected growth potential of Caris fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Caris Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.25)
Revenue Per Share
3.18
Quarterly Revenue Growth
0.499
The market value of Caris Life Sciences is measured differently than its book value, which is the value of Caris that is recorded on the company's balance sheet. Investors also form their own opinion of Caris Life's value that differs from its market value or its book value, called intrinsic value, which is Caris Life's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Caris Life's market value can be influenced by many factors that don't directly affect Caris Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Technical
Analysis
Details
It's important to distinguish between Caris Life's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Caris Life should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Caris Life's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY